US Map / Colorado
State CO

Clinical Trials in Colorado

Colorado is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Colorado and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 278 actively recruiting studies with Colorado sites out of 278 registered in total. The busiest research areas in Colorado are Advanced Solid Tumor, Breast Cancer, Carcinoma, Non-Small-Cell Lung. Leading sponsors running trials in the state include University of Colorado, Denver, Merck Sharp & Dohme LLC, National Cancer Institute (NCI). By stage, Colorado trials break down as Phase 1 (53), Phase 2 (84), Phase 3 (71), Phase 4 (5).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
278
Recruiting Now
278
← Back to US Map
Top Conditions in Colorado
Advanced Solid Tumor (5)Breast Cancer (4)Carcinoma, Non-Small-Cell Lung (4)Malignant Neoplasm (3)Multiple Myeloma (3)B Acute Lymphoblastic Leukemia (3)Metastatic Breast Cancer (3)Kidney Diseases (3)Pancreatic Ductal Adenocarcinoma (3)Pulmonary Hypertension (3)Alzheimer Disease (3)Type 1 Diabetes (3)

Frequently Asked Questions — Clinical Trials in Colorado

How many clinical trials are currently recruiting in Colorado?
ClinicalMetric currently tracks 278 actively recruiting clinical trials with at least one location in Colorado. The total number of registered studies—including active but not currently enrolling trials—is 278. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Colorado?
Colorado hosts clinical trials across a broad range of medical conditions, including Advanced Solid Tumor, Breast Cancer, Carcinoma, Non-Small-Cell Lung, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Colorado serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Colorado?
To join a clinical trial in Colorado, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Colorado maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Colorado

NCT06875310 Phase 3
Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembr...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
630 pts
Location
United States, Argentina, Australia
Sponsor
Mirati Therapeutics Inc.
View Trial →
NCT06430541 Phase 1
Recruiting
Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence
Condition
Breast Cancer
Enrollment
20 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT04219254 Phase 1, Phase 2
Recruiting
A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced S...
Condition
Solid Tumor, Adult
Enrollment
197 pts
Location
United States, Georgia, Germany
Sponsor
BioInvent International AB
View Trial →
NCT06072131 Phase 3
Recruiting
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP A...
Condition
Peripheral T Cell Lymphoma
Enrollment
504 pts
Location
United States, Canada, Germany
Sponsor
Acrotech Biopharma Inc.
View Trial →
NCT04142437 N/A
Recruiting
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI Duri...
Condition
Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion
Enrollment
150 pts
Location
United States, Argentina, Australia
Sponsor
Bayer
View Trial →
NCT07011732 Phase 3
Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the T...
Condition
Alzheimer Disease
Enrollment
426 pts
Location
United States, Argentina, Brazil
Sponsor
Bristol-Myers Squibb
View Trial →
NCT07517263 Phase 3
Recruiting
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to E...
Condition
Cardiovascular Disease and Lipoprotein(a)
Enrollment
5,700 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT07227415 Phase 1, Phase 2
Recruiting
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Al...
Condition
Carcinoma, Renal Cell
Enrollment
224 pts
Location
United States, Australia, China
Sponsor
Pfizer
View Trial →
NCT05266976 N/A
Recruiting
Mode of Exercise and Bone Biomarkers in Older Veterans
Condition
Aging
Enrollment
120 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT06848348 Phase 2
Recruiting
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced ...
Condition
Chemotherapy Induced Neuropathic Pain
Enrollment
240 pts
Location
United States
Sponsor
Dogwood Therapeutics Inc.
View Trial →
NCT06727604 Phase 2
Recruiting
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatme...
Condition
Graves' Disease
Enrollment
240 pts
Location
United States, Belgium, Georgia
Sponsor
Immunovant Sciences GmbH
View Trial →
NCT07190807 N/A
Recruiting
Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent...
Condition
Chronic Pain
Enrollment
70 pts
Location
United States
Sponsor
Boston Scientific Corporation
View Trial →
NCT06445608 N/A
Recruiting
PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm
Condition
Coronary Artery Disease
Enrollment
310 pts
Location
United States
Sponsor
Kardion Inc
View Trial →
NCT03949855 Phase 2
Recruiting
Belimumab With Rituximab for Primary Membranous Nephropathy
Condition
Membranous Nephropathy
Enrollment
58 pts
Location
United States
Sponsor
National Institute of Allergy
View Trial →
NCT07198074 Phase 3
Recruiting
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Ca...
Condition
Advanced Endometrial Carcinoma
Enrollment
255 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06317662 Phase 2
Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer I...
Condition
Acute Leukemia of Ambiguous Lineage
Enrollment
153 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06112418 N/A
Recruiting
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Pr...
Condition
Diabetes Mellitus, Type 2
Enrollment
7,500 pts
Location
United States
Sponsor
Cleerly, Inc.
View Trial →
NCT06714591 Phase 1
Recruiting
Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1
Condition
Relapsed/Refractory Acute Myeloid Leukemia
Enrollment
120 pts
Location
United States
Sponsor
SystImmune Inc.
View Trial →
NCT07361510 Phase 3
Recruiting
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participan...
Condition
Non-Small Cell Lung Cancer (NSCLC)
Enrollment
750 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT02480283 N/A
Recruiting
Chronic Cannabis Smoking, Oxidative Stress and the Pulmonary Innate Immune Respo...
Condition
Cannabis Smoking
Enrollment
100 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT05201469 Phase 2
Recruiting
VIBRANT: VIB4920 for Active Lupus Nephritis
Condition
Lupus Nephritis
Enrollment
74 pts
Location
United States
Sponsor
National Institute of Allergy
View Trial →
NCT07113522 Phase 2
Recruiting
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Condition
Inflammatory Bowel Disease (IBD)
Enrollment
140 pts
Location
United States, Canada, Georgia
Sponsor
Mirador Therapeutics, Inc.
View Trial →
NCT05410145 Phase 1, Phase 2
Recruiting
A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced ...
Condition
KRAS P.G12C
Enrollment
442 pts
Location
United States, Australia, China
Sponsor
D3 Bio (Wuxi) Co., Ltd
View Trial →
NCT06670053 N/A
Recruiting
Puberty, Testosterone, and Brain Development
Condition
Gender Identity
Enrollment
100 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT03683251 Phase 3
Recruiting
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Condition
Neovascular Age-Related Macular Degeneration
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
View Trial →
Page 8 of 12 — 278 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology